The FDA go-ahead tees up a battle with rival Novo Nordisk over the next front in the booming weight-loss drug market.
Source link
About The Author
The FDA approved Eli Lilly’s new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market